Shorter sampling interval in pilot - Good idea? [Design Issues]

posted by ElMaestro  – Denmark, 2018-02-27 22:42 (2332 d 04:57 ago) – Posting: # 18473
Views: 3,289

Hy yourself,

❝ Sponsor wants to make a little cheaper by having only 24 h sampling in the pilot, but considerably longer in the pivotal trial.


❝ Good idea? Regarding sample size estimation for the pivotal (including adjusted acceptance range for Cmax, but standard acceptance range for AUC...).


That's likely going to be fine. It will regularly be Cmax that is the showstopper. Even if your AUC does not cover 80% and if you are not sampling to 72hrs, then the idea you get about AUC aspects will still be very qualified.

Note one thing which is commonly misunderstood: When pilot trials have small sample sizes compared to pivotal studies (which is almost a definition) then they do not give good info about formulation matches in BE (or, where applicable, of superiority prospects, but this is often very dependent of placebo arms).
Pilot BE studies are great for everything but screening for formulation matches.:-)

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,107 posts in 4,858 threads, 1,644 registered users;
56 visitors (0 registered, 56 guests [including 10 identified bots]).
Forum time: 04:39 CEST (Europe/Vienna)

All paid jobs absorb and degrade the mind.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5